DCGI approves anti-COVID drug developed by DRDO for emergency use

According to Defence Research and Development Organisation (DRDO) statement, an anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO in collaboration with Dr Reddy's Laboratories, Hyderabad.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3nX3LXA
via IFTTT